Over the past year, Maggie’s Mission has raised $282,426 for MSK – 100% of this funding has supported vital pediatric cancer research, specifically a ground-breaking Malignant Rhabdoid Tumor research study.
Malignant Rhabdoid Tumor (MRT) Research Study
Pediatric sarcomas are very rare bone or soft tissue cancers. There are more than 50 unique subtypes of sarcoma, including MRT, each of which may respond to a different targeted therapy. One way to personalize treatment is immunotherapy, which harnesses the power of the immune system to attack cancer cells.
Maggie’s Mission is the sole funder of a game-changing MRT study at MSK.
Thanks to donations to Maggie’s Mission, Dr. Alex Kentsis and Dr. Srikanth Ambati launched a new study that investigates the links between the genetics of MRT and treatment effectiveness. This data can then be used to match patients with specific mutations to the appropriate immunotherapy treatments and clinical trials, giving new hope to children battling this incredibly rare cancer.
Our financials to date:
With your help, we have raised over $350,000 since September, 2017
What we are doing
Funded $282,426 towards the MRT Research project at Memorial Sloan Kettering
Provided $17,264 in financial assistance to local families affected by a pediatric cancer diagnosis
Donated $3,000 from our event "Music for Maggie" to two Harborfields High School students
Ronald McDonald House in NYC
Serving meals at the Ronald McDonald House in NYC - $3,837